Talk:COVID-19 drug repurposing research
This is the talk page for discussing improvements to the COVID-19 drug repurposing research article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1, 2Auto-archiving period: 14 days |
This article is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
|
WikiProject COVID-19 consensus WikiProject COVID-19 aims to add to and build consensus for pages relating to COVID-19. They have so far discussed items listed below. Please discuss proposed improvements to them at the project talk page.
To ensure you are viewing the current list, you may wish to . |
Daily pageviews of this article
A graph should have been displayed here but graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at pageviews.wmcloud.org |
This is the talk page for discussing improvements to the COVID-19 drug repurposing research article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1, 2Auto-archiving period: 14 days |
The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page. |
Extended-confirmed-protected edit request on 28 June 2021
This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
Propose adding to the ivermectin section: "Despite the lack of FDA approval for COVID-19 treatment, an increase in off-label ivermectin prescriptions occurred in the US[1] following initial publications showing potential benefit. "During March 16, 2019–April 2, 2021, national estimates of ivermectin dispensed from outpatient retail pharmacies increased from an average of 3589 prescriptions per week at the pre-pandemic baseline to a peak of 39,102 prescriptions in the week ending on January 8, 2021 (989% relative percent increase)"[2]
I think this would follow well after "Ivermectin is not approved by the U.S. Food and Drug Administration (FDA) for use in treating any viral illness and is not authorized for use to treat COVID-19 within the European Union" Caprilyc (talk) 13:39, 28 June 2021 (UTC)
References
- ^ Lind, Jennifer; Lovegrove, Maribeth; Geller, Andrew; Uyeki, Timothy; Datta, S Deblina; Budnitz, Daniel (18 June 2021). "Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A Cross-Sectional Analysis". Journal of General Internal Medicine. doi:10.1007/s11606-021-06948-6.
- ^ Geller, Andrew; Lovegrove, Maribeth; Lind, Jennifer (11 Feb 2021). "Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by US Retail Pharmacies During the Pandemic". JAMA Internal Medicine. 181 (6): 869–872. doi:10.1001/jamainternmed.2021.0299.
- Not done The source for "showing potential benefit" is a letter, and doesn't support it in any case. More generall this is not relevant to the topic of "drug repurposing research". Maybe something respectful of WP:V could be due at COVID-19 misinformation. Alexbrn (talk) 13:58, 28 June 2021 (UTC)
- I don't have edit access there and the talk page is locked as well but propose adding "Despite the lack of FDA approval for COVID-19 treatment, an increase in off-label ivermectin prescriptions occurred in the US[1] following widespread media coverage of the drug. "During March 16, 2019–April 2, 2021, national estimates of ivermectin dispensed from outpatient retail pharmacies increased from an average of 3589 prescriptions per week at the pre-pandemic baseline to a peak of 39,102 prescriptions in the week ending on January 8, 2021 (989% relative percent increase)"[2] Caprilyc (talk) 15:20, 28 June 2021 (UTC)
- Caprilyc possibly also at Ivermectin and/or COVID-19 pandemic in the United States if it's notable. Alaexis¿question? 14:43, 28 June 2021 (UTC)
- Point taken. I did not mean to add it as an endorsement of efficacy, more as a statement on how even very preliminary scientific findings affected physician behavior in the field. Given that there is discussion of people taking horse dewormer perhaps that is also better moved to COVID-19 misinformation instead of this research section. Caprilyc (talk) 15:01, 28 June 2021 (UTC)
- Not done: it's not clear what changes you want to be made. Please mention the specific changes in a "change X to Y" format and provide a reliable source if appropriate. Melmann 09:29, 30 June 2021 (UTC)
Extended-confirmed-protected edit request on 1 July 2021
This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
Concerning Ivermectin, it seems reasonable to include a statement, such as:
The National Institute of Health (NIH) is currently neutral in its stance on the efficacy of Ivermectin as a COVID-19 therapy: "There are insufficient data for the COVID-19 Treatment Guidelines Panel (the Panel) to recommend either for or against the use of ivermectin for the treatment of COVID-19. Results from adequately powered, well-designed, and well-conducted clinical trials are needed to provide more specific, evidence-based guidance on the role of ivermectin in the treatment of COVID-19." "Some observational cohorts and clinical trials have evaluated the use of ivermectin for the prevention and treatment of COVID-19." See, https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/ 2600:8802:330F:A00:895B:ADAD:F26F:315A (talk) 20:04, 1 July 2021 (UTC)
References
- ^ Lind, Jennifer; Lovegrove, Maribeth; Geller, Andrew; Uyeki, Timothy; Datta, S Deblina; Budnitz, Daniel (18 June 2021). "Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A Cross-Sectional Analysis". Journal of General Internal Medicine. doi:10.1007/s11606-021-06948-6.
- ^ Geller, Andrew; Lovegrove, Maribeth; Lind, Jennifer (11 Feb 2021). "Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by US Retail Pharmacies During the Pandemic". JAMA Internal Medicine. 181 (6): 869–872. doi:10.1001/jamainternmed.2021.0299.
- Not done The position of the NIH is already included in the article. Alexbrn (talk) 20:11, 1 July 2021 (UTC)
Invermectin again. Claimed peer reviewed meta-analysis.
This any use? https://journals.lww.com/americantherapeutics/Fulltext/2021/06000/Review_of_the_Emerging_Evidence_Demonstrating_the.4.aspx
Regards all. Springnuts (talk) 06:49, 2 July 2021 (UTC)
- No. It's been raised (in at least 3 sections) at Talk:Ivermectin. Alexbrn (talk) 06:57, 2 July 2021 (UTC)
Thank you. Springnuts (talk) 19:12, 3 July 2021 (UTC)
Extended-confirmed-protected edit request on 4 July 2021
This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
There is now peer reviewed evidence that Ivermectin does work for CoVid. https://journals.lww.com/americantherapeutics/Abstract/9000/Ivermectin_for_Prevention_and_Treatment_of.98040.aspx 108.243.106.82 (talk) 23:45, 4 July 2021 (UTC)
- Not done The URL throws a 404 error. dudhhrContribs 02:45, 6 July 2021 (UTC)
Chloroquine and hydroxycholoquine
For Ivermectin it is correctly written that “some governments have allowed its off-label use”, including India (despite the opinion comments added like “Misinformation”, “despair”…). But this is not written for Chloroquine and hydroxycholoquine, despite the fact that Indian Ministry oh Health advises the use of hydroxycholoquine for mild cases in its latest Clinical management protocol, amended on May 24 2021.
The Protocol https://www.mohfw.gov.in/pdf/UpdatedDetailedClinicalManagementProtocolforCOVID19adultsdated24052021.pdf,
Article about the amended protocol and ivermectin Hundustan Times,
Article about the amended protocol and hydroxycholoquine Times of India.
Could someone add the info, at least for hydroxycholoquine? I have not enough edits to be able to do it myself… Thanks. Ceveris (talk) 10:38, 10 July 2021 (UTC)
- B-Class COVID-19 articles
- High-importance COVID-19 articles
- WikiProject COVID-19 articles
- B-Class medicine articles
- Mid-importance medicine articles
- B-Class society and medicine articles
- Mid-importance society and medicine articles
- Society and medicine task force articles
- B-Class pulmonology articles
- Mid-importance pulmonology articles
- Pulmonology task force articles
- All WikiProject Medicine pages
- B-Class pharmacology articles
- Mid-importance pharmacology articles
- WikiProject Pharmacology articles
- B-Class virus articles
- Mid-importance virus articles
- WikiProject Viruses articles
- B-Class Disaster management articles
- Mid-importance Disaster management articles
- B-Class International relations articles
- Mid-importance International relations articles
- WikiProject International relations articles